J&J pauses vaccine trials due to unexplained illness

    0
    47
    An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. - The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson. (Photo by Mark RALSTON / AFP) (Photo credit should read MARK RALSTON/AFP via Getty Images)

    Johnson & Johnson said on Monday it has temporarily paused its covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant. The participant’s illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company’s clinical and safety physicians, it said in a statement.

    Stat News reported the pause earlier in the day citing a document sent to outside researchers running the 60,000-patient clinical trial, which stated that a ‘pausing rule’ had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened.

    AS

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.